|
Delayed
Nasdaq
01:30:00 15/08/2025 am IST
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 332.12Cr 286.72Cr 268.99Cr 245Cr 460.68Cr 32TCr 467.06Cr 3.15TCr 1.24TCr 16TCr 1.25TCr 1.22TCr 53TCr | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 347.73Cr 300.19Cr 281.63Cr 256.51Cr 482.32Cr 33TCr 489.01Cr 3.3TCr 1.29TCr 17TCr 1.31TCr 1.28TCr 55TCr | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/25/30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/25/30 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/25/30 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/25/30 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/25/24 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 3 years | 82.15 |  | 101.02 |
| 5 years | 69.36 | | 188.88 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Chief Executive Officer | 5,20,347 | 1.5886% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 223.64Cr 193.07Cr 181.13Cr 164.97Cr 310.2Cr 21TCr 314.5Cr 2.12TCr 832.05Cr 11TCr 839.63Cr 821.45Cr 36TCr | 234.83Cr 202.73Cr 190.19Cr 173.23Cr 325.73Cr 22TCr 330.24Cr 2.23TCr 873.69Cr 11TCr 881.65Cr 862.56Cr 37TCr |
| Net income | -97.47L -84.15L -78.94L -71.9L -1.35Cr -93Cr -1.37Cr -9.25Cr -3.63Cr -47Cr -3.66Cr -3.58Cr -155.31Cr | 4.32Cr 3.73Cr 3.5Cr 3.19Cr 6Cr 413.35Cr 6.08Cr 41Cr 16Cr 207.09Cr 16Cr 16Cr 688.86Cr |
| Net Debt | 36Cr 31Cr 29Cr 27Cr 50Cr 3.45TCr 51Cr 342.52Cr 134.22Cr 1.73TCr 135.44Cr 132.51Cr 5.75TCr | 16Cr 13Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 148.17Cr 58Cr 747.56Cr 59Cr 57Cr 2.49TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
